| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.034 | 0.6 |